|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.005 CHF | -2.51% |
|
+5.26% | -64.94% |
| Jul. 11 | DOCMORRIS : Receives a Buy rating from Jefferies | ZD |
| Jul. 03 | DOCMORRIS : Deutsche Bank reaffirms its Neutral rating | ZD |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,708 | 2,412 | 320.6 | 867.3 | 257.7 | 336.2 | - | - |
| Change | - | -10.94% | -86.71% | 170.52% | -70.29% | 30.49% | - | - |
| Enterprise Value (EV) 1 | 2,978 | 2,714 | 723.2 | 1,144 | 486.1 | 598.1 | 585.1 | 593.5 |
| Change | - | -8.85% | -73.36% | 58.2% | -57.51% | 23.03% | -2.17% | 1.44% |
| P/E ratio | -18.9x | -10.1x | -1.61x | 10.5x | -2.42x | -2.24x | -3.74x | -9.54x |
| PBR | 5.09x | 5.44x | 0.84x | 2.01x | 0.69x | 0.6x | 0.56x | 0.71x |
| PEG | - | -0.2x | 0.1x | -0x | 0x | 0x | 0.1x | 0.2x |
| Capitalization / Revenue | 1.83x | 1.4x | 0.2x | 0.9x | 0.25x | 0.29x | 0.25x | 0.21x |
| EV / Revenue | 2.02x | 1.57x | 0.45x | 1.18x | 0.48x | 0.51x | 0.43x | 0.37x |
| EV / EBITDA | -38x | -19x | -9.31x | -29.8x | -10x | -16x | -116x | 21.9x |
| EV / EBIT | -25.3x | -14x | -5.15x | -13.8x | -5.41x | -7.32x | -11.6x | -36.6x |
| EV / FCF | -23.4x | -14x | -3.87x | -9.94x | -8.81x | -6.93x | -10.8x | -19.4x |
| FCF Yield | -4.27% | -7.15% | -25.9% | -10.1% | -11.4% | -14.4% | -9.24% | -5.16% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -14.95 | -23.4 | -15.88 | 7.05 | -8.25 | -3.125 | -1.873 | -0.7341 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,477 | 1,726 | 1,608 | 966.9 | 1,017 | 1,171 | 1,365 | 1,608 |
| EBITDA 1 | -78.4 | -142.6 | -77.7 | -38.4 | -48.6 | -37.28 | -5.026 | 27.14 |
| EBIT 1 | -117.6 | -193.8 | -140.3 | -83.2 | -89.8 | -81.73 | -50.53 | -16.2 |
| Net income 1 | -135.6 | -225.7 | -171.1 | 82.2 | -97.3 | -98.01 | -64.76 | -34.8 |
| Net Debt 1 | 270 | 302.8 | 402.6 | 276.8 | 228.4 | 261.8 | 248.8 | 257.3 |
| Reference price 2 | 283.000 | 235.500 | 25.560 | 73.750 | 19.980 | 7.005 | 7.005 | 7.005 |
| Nbr of stocks (in thousands) | 9,568 | 10,240 | 12,543 | 11,760 | 12,897 | 47,999 | - | - |
| Announcement Date | 3/18/21 | 3/24/22 | 3/24/23 | 3/20/24 | 3/12/25 | - | - | - |
1CHF in Million2CHF
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.24x | 0.51x | -16.04x | -.--% | 422M | ||
| 33.62x | 1.45x | 36.28x | -.--% | 17.37B | ||
| -2.93x | 0.1x | 4.41x | 5.64% | 9.97B | ||
| 30.17x | 1.6x | 25.2x | -.--% | 8.97B | ||
| 21.52x | 1x | 10.05x | 1.52% | 8.41B | ||
| 26.08x | 1.66x | 12.19x | 2.47% | 4.73B | ||
| 19.57x | 1.73x | 10.12x | 4.23% | 4.46B | ||
| 16.61x | 1.02x | 7.51x | 2.58% | 4.14B | ||
| 22.63x | 0.41x | 8.64x | 1.42% | 3.65B | ||
| Average | 18.34x | 1.05x | 10.93x | 1.98% | 6.9B | |
| Weighted average by Cap. | 22.01x | 1.13x | 18.40x | 1.86% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
